Christopher Bloomstran - Semper Augustus Investments Group
Holding/activity history for Sanofi Aventis (SNY)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2018 Q4 | 0 | 0.00 | Sell 100.00% | 3.18 | SEC | ||
| 2018 Q3 | 123,472 | 3.18 | $44.67 | $5,515,000 | SEC | ||
| 2018 Q2 | 123,472 | 3.09 | Add 18.63% | 0.49 | $40.01 | $4,940,000 | SEC |
| 2018 Q1 | 104,085 | 2.90 | Reduce 1.00% | 0.03 | $40.08 | $4,172,000 | SEC |
| 2017 Q4 | 105,138 | 3.39 | Reduce 0.05% | <0.01 | $43.00 | $4,521,000 | SEC |
| 2017 Q3 | 105,188 | 3.87 | $49.79 | $5,237,000 | SEC | ||
| 2017 Q2 | 105,188 | 3.87 | Reduce 0.07% | <0.01 | $47.91 | $5,040,000 | SEC |
| 2017 Q1 | 105,260 | 3.56 | Reduce 0.33% | 0.01 | $45.25 | $4,763,000 | SEC |
| 2016 Q4 | 105,610 | 3.34 | Reduce 0.16% | <0.01 | $40.44 | $4,271,000 | SEC |
| 2016 Q3 | 105,774 | 3.06 | Add 4.17% | 0.12 | $38.19 | $4,040,000 | SEC |
| 2016 Q2 | 101,539 | 3.21 | Add 23.30% | 0.61 | $41.85 | $4,249,000 | SEC |
| 2016 Q1 | 82,350 | 2.46 | Reduce 1.05% | 0.03 | $40.16 | $3,307,000 | SEC |
| 2015 Q4 | 83,220 | 2.59 | $42.65 | $3,549,000 | SEC | ||
| 2015 Q3 | 83,220 | 2.90 | Reduce 5.43% | 0.17 | $47.46 | $3,950,000 | SEC |
| 2015 Q2 | 88,000 | 3.08 | Reduce 0.16% | <0.01 | $49.53 | $4,359,000 | SEC |
| 2015 Q1 | 88,140 | 2.98 | $49.44 | $4,358,000 | SEC | ||
| 2014 Q4 | 88,140 | 2.70 | Reduce 0.40% | 0.01 | $45.61 | $4,020,000 | SEC |
| 2014 Q3 | 88,490 | 3.22 | $56.42 | $4,993,000 | SEC | ||
| 2014 Q2 | 88,490 | 2.91 | Reduce 0.06% | <0.01 | $53.17 | $4,705,000 | SEC |
| 2014 Q1 | 88,540 | 2.81 | $52.28 | $4,629,000 | SEC | ||
| 2013 Q4 | 88,540 | 2.84 | Reduce 0.08% | <0.01 | $53.63 | $4,748,000 | SEC |
| 2013 Q3 | 88,615 | 2.80 | $50.63 | $4,487,000 | SEC | ||
| 2013 Q2 | 88,615 | 2.84 | Buy | 2.84 | $51.51 | $4,565,000 | SEC |
| 2011 Q1 | 0 | 0.00 | Sell 100.00% | 2.53 | SEC | ||
| 2010 Q4 | 80,565 | 2.53 | Buy | 2.53 | $32.23 | $2,597,000 | SEC |